Identification of the Novel HLA‐B*46:107 Allele Using Nanopore Sequencing
HLA · 2025
DOI: 10.1111/tan.70401 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2025. Verfasst von Hengcong Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nanning Institute of Transfusion Medicine, Nanning Blood Center, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Alleles, Exons, Nanopore Sequencing, HLA-B Antigens. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 2 Literaturangaben. Gefördert von: Natural Science Foundation of Guangxi Zhuang Autonomous Region, Fourth-cycle Medical Key Laboratory Construction Project.
Abstract (Originalsprache)
HLA‐B*46:107 differs from HLA‐B*46:01:01:01 by one nucleotide substitution at codon 83 in exon 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nanning Institute of Transfusion Medicine, Nanning Blood Center, Nanning, Guangxi, China.
ORCID-Profile: Hengcong Li
Förderung
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
- Fourth-cycle Medical Key Laboratory Construction Project
Zitieren
APA
Li, H., Li, L., Lu, F., Chen, J., & Jiang, L. (2025). Identification of the Novel HLA‐B*46:107 Allele Using Nanopore Sequencing. HLA. https://doi.org/10.1111/tan.70401
Vancouver
Li H, Li L, Lu F, Chen J, Jiang L. Identification of the Novel HLA‐B*46:107 Allele Using Nanopore Sequencing. HLA. 2025. doi:10.1111/tan.70401
BibTeX
@article{Li2025,
author = {Li, Hengcong and Li, Lilan and Lu, Fang and Chen, Jierun and Jiang, Lihong},
title = {Identification of the Novel HLA‐B*46:107 Allele Using Nanopore Sequencing},
journal = {HLA},
year = {2025},
doi = {10.1111/tan.70401}
}
EUVIMED